Omada Health (OMDA) is a strong buy. Backed by 29 studies, key partnerships with Cigna and CVS drive growth, credibility, and ...

Sword Health, a company that provides virtual physical therapy and mental health, is now offering an AI assistant for payers ...

Executives at smaller investment banks are giving bullish forecasts for equity capital markets for the rest of the year.

Venture capital investment across the healthcare sector slowed in the first half of the year, but investors are spending on ...

The digital health market is welcoming new IPOs for the first time in years. Bankers and investors think these 9 startups ...

Omada Health is poised to generate over 35% growth while approaching adjusted EBITDA breakeven, Needham analysts say.

Healthcare startups are betting that AI can help them do more with less — including in caring for patients.

University of Florida researchers said a new study could lead to a universal cancer shot, while digital health earnings ...

Investing.com - Freedom Broker initiated coverage on Omada Health Inc (NASDAQ:OMDA) with a Buy rating and a $26.00 price target, representing approximately 40% upside from current levels ...

Additionally, Omada Health granted underwriters a 30-day option to purchase up to an extra 1,185,000 shares at the IPO price, excluding underwriting discounts and commissions.

Omada Health CPO Nancy Vitale's focus on company culture's role in attracting talent means putting great effort into the policies that matter most.

Omada Health has established a customer base exceeding 2,000 clients, targeting employers, health plans, pharmacy benefit managers, and health systems with an engagement-based billing model to drive ...